AU2345695A - Pharmaceutical composition for transdermal delivery - Google Patents

Pharmaceutical composition for transdermal delivery

Info

Publication number
AU2345695A
AU2345695A AU23456/95A AU2345695A AU2345695A AU 2345695 A AU2345695 A AU 2345695A AU 23456/95 A AU23456/95 A AU 23456/95A AU 2345695 A AU2345695 A AU 2345695A AU 2345695 A AU2345695 A AU 2345695A
Authority
AU
Australia
Prior art keywords
pharmaceutical composition
transdermal delivery
transdermal
delivery
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU23456/95A
Inventor
Charanjit Rai Behl
Peter Hofmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/234,214 external-priority patent/US5580574A/en
Priority claimed from US08/234,216 external-priority patent/US5552153A/en
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of AU2345695A publication Critical patent/AU2345695A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU23456/95A 1994-04-28 1995-04-21 Pharmaceutical composition for transdermal delivery Abandoned AU2345695A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/234,214 US5580574A (en) 1994-04-28 1994-04-28 Pharmaceutical composition for transdermal delivery
US234216 1994-04-28
US08/234,216 US5552153A (en) 1994-04-28 1994-04-28 Pharmaceutical composition for transdermal delivery
US234214 1994-04-28
PCT/EP1995/001519 WO1995029678A1 (en) 1994-04-28 1995-04-21 Pharmaceutical composition for transdermal delivery

Publications (1)

Publication Number Publication Date
AU2345695A true AU2345695A (en) 1995-11-29

Family

ID=26927678

Family Applications (1)

Application Number Title Priority Date Filing Date
AU23456/95A Abandoned AU2345695A (en) 1994-04-28 1995-04-21 Pharmaceutical composition for transdermal delivery

Country Status (2)

Country Link
AU (1) AU2345695A (en)
WO (1) WO1995029678A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL121623A (en) 1997-08-26 2000-06-29 Unipharm Ltd Process for the preparation of solid oral dosage forms comprising alendronic acid
IT1294748B1 (en) * 1997-09-17 1999-04-12 Permatec Tech Ag FORMULATION FOR A TRANSDERMAL DEVICE
AU747041B2 (en) 1997-11-10 2002-05-09 Strakan International Limited Penetration enhancing and irritation reducing systems
US6921497B2 (en) 1999-10-13 2005-07-26 Electromagnetics Corporation Composition of matter tailoring: system I
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
US6986812B2 (en) * 2003-09-18 2006-01-17 United States Gypsum Company Slurry feed apparatus for fiber-reinforced structural cementitious panel production
ATE534373T1 (en) * 2003-10-10 2011-12-15 Antares Pharma Ipl Ag TRANSDERMAL PHARMACEUTICAL FORMULATION TO MINIMIZE RESIDUE ON THE SKIN
US7387788B1 (en) 2003-10-10 2008-06-17 Antares Pharma Ipl Ag Pharmaceutical compositions of nicotine and methods of use thereof
WO2006125642A1 (en) 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
CN101426475A (en) 2006-04-21 2009-05-06 安塔雷斯制药Ipl股份公司 Methods of treating hot flashes with formulations for transdermal or transmucosal application
TW200824693A (en) * 2006-08-28 2008-06-16 Jazz Pharmaceuticals Inc Pharmaceutical compositions of clonazepam and methods of use thereof
US9050293B2 (en) 2008-07-16 2015-06-09 Juventio, Llc Small molecule solubilization system
WO2010094074A1 (en) * 2009-02-20 2010-08-26 Palmaya Pty Ltd Pharmaceutical preparation and delivery system
WO2012006683A1 (en) * 2010-07-16 2012-01-19 Controlled Release Technologies Pty Ltd Pharmaceutical compositions for sustained delivery of benzodiazepine antagonists
NZ701435A (en) 2010-11-22 2016-01-29 Electromagnetics Corp Tailoring a metal or modifying an electronic structure thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4722941A (en) * 1978-06-07 1988-02-02 Kali-Chemie Pharma Gmbh Readily absorbable pharmaceutical compositions of per se poorly absorbable pharmacologically active agents and preparation thereof
CA1249968A (en) * 1984-04-05 1989-02-14 Kazuo Kigasawa Ointment base

Also Published As

Publication number Publication date
WO1995029678A1 (en) 1995-11-09

Similar Documents

Publication Publication Date Title
ZA962536B (en) Pharmaceutical composition for transdermal administration.
AUPN605795A0 (en) Analgesic pharmaceutical composition
HUP9802983A3 (en) Composition for transdermal delivery
AU6740298A (en) Pharmaceutical composition
AUPN411195A0 (en) Medicinal composition
AU5136998A (en) Medicinal composition
AU7590096A (en) Drug composition
AU1689999A (en) Medicinal composition for percutaneous administration
AU6175398A (en) New delivery system for administering dentin-hypersensitivity-ameliorating compositions
AU2345695A (en) Pharmaceutical composition for transdermal delivery
AU5155096A (en) Pharmaceutical composition
AU7904998A (en) Pharmaceutical composition containing peptichemio
AU2531295A (en) Pharmaceutical composition
AU6998196A (en) Medicinal composition for diabetes
AU9343098A (en) Pharmaceutical composition
AU7735798A (en) Pharmaceutical composition for oral administration
AU1544195A (en) Pharmaceutical compositions
AU1427895A (en) Pharmaceutical compositions
AU5041190A (en) Transdermal drug delivery composition
AU6814496A (en) Pharmaceutical composition
AU1880599A (en) Pharmaceutical composition for oral administration
AUPN007494A0 (en) Pharmaceutical composition
AUPM841894A0 (en) Pharmaceutical composition
AUPM341094A0 (en) Pharmaceutical composition
AU741226C (en) Pharmaceutical composition